Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORMEDI DANMARK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   6.0% 5.7% 4.2% 7.1% 5.2% 4.9% 9.9% 9.9%   Credit score (0-100)   40 40 47 33 42 44 25 25   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,725 2,276 1,576 2,701 915 990 0.0 0.0   EBITDA   879 1,353 709 1,730 309 -19.0 0.0 0.0   EBIT   818 1,291 656 1,723 309 -52.7 0.0 0.0   Pre-tax profit (PTP)   813.0 1,277.2 618.8 1,706.4 241.7 -83.5 0.0 0.0   Net earnings   624.5 986.1 474.0 1,314.5 175.4 -74.1 0.0 0.0   Pre-tax profit without non-rec. items   813 1,277 619 1,706 242 -83.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   121 59.5 6.2 0.0 0.0 87.6 0.0 0.0   Shareholders equity total   677 1,063 637 1,365 1,540 1,466 1,416 1,416   Interest-bearing liabilities   345 602 491 1,189 420 286 0.0 0.0   Balance sheet total (assets)   1,959 3,956 2,057 4,084 2,699 2,279 1,416 1,416   Net Debt   -571 -2,106 -472 -413 -1,559 -1,031 -1,416 -1,416     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,725 2,276 1,576 2,701 915 990 0.0 0.0   Gross profit growth   133.6% 31.9% -30.7% 71.3% -66.1% 8.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,959 3,956 2,057 4,084 2,699 2,279 1,416 1,416   Balance sheet change%   65.8% 101.9% -48.0% 98.5% -33.9% -15.6% -37.9% 0.0%   Added value   879.1 1,352.6 709.0 1,729.6 315.5 -19.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   38 -123 -107 -12 0 54 -88 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   47.4% 56.7% 41.6% 63.8% 33.8% -5.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   53.0% 44.4% 22.0% 56.5% 9.4% -1.9% 0.0% 0.0%   ROI %   106.2% 96.9% 47.3% 94.3% 14.1% -2.5% 0.0% 0.0%   ROE %   162.3% 113.3% 55.7% 131.3% 12.1% -4.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   34.6% 26.9% 31.0% 33.4% 57.1% 64.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -64.9% -155.7% -66.6% -23.9% -504.0% 5,416.4% 0.0% 0.0%   Gearing %   50.9% 56.6% 77.1% 87.1% 27.3% 19.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.1% 7.7% 7.7% 3.5% 9.4% 10.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.5 1.3 1.4 1.5 2.3 2.7 0.0 0.0   Current Ratio   1.5 1.3 1.4 1.5 2.3 2.7 0.0 0.0   Cash and cash equivalent   915.6 2,708.0 963.2 1,602.4 1,978.9 1,316.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   580.4 1,003.8 631.0 1,364.8 1,540.1 1,378.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   879 1,353 709 1,730 316 -19 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   879 1,353 709 1,730 309 -19 0 0   EBIT / employee   818 1,291 656 1,723 309 -53 0 0   Net earnings / employee   624 986 474 1,315 175 -74 0 0